Therapeutic effects of dexamethasone-loaded hyaluronan nanogels in the experimental cholestasis.
Cholestasis
Dexamethasone
Hyaluronic acid
Nanogels
Primary biliary cholangitis
Journal
Drug delivery and translational research
ISSN: 2190-3948
Titre abrégé: Drug Deliv Transl Res
Pays: United States
ID NLM: 101540061
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
accepted:
04
02
2022
pubmed:
1
3
2022
medline:
2
7
2022
entrez:
28
2
2022
Statut:
ppublish
Résumé
A major function of the intrahepatic biliary epithelium is bicarbonate excretion in bile. Recent reports indicate that budesonide, a corticosteroid with high receptor affinity and hepatic first pass clearance, increases the efficacy of ursodeoxycholic acid, a choleretic agent, in primary biliary cholangitis patients. We have previously reported that bile ducts isolated from rats treated with dexamethasone or budesonide showed an enhanced activity of the Na
Identifiants
pubmed: 35226290
doi: 10.1007/s13346-022-01132-7
pii: 10.1007/s13346-022-01132-7
pmc: PMC9242918
doi:
Substances chimiques
Bicarbonates
0
Nanogels
0
Budesonide
51333-22-3
Dexamethasone
7S5I7G3JQL
Hyaluronic Acid
9004-61-9
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1959-1973Informations de copyright
© 2022. The Author(s).
Références
Lazaridis KN, LaRusso NF. The cholangiopathies. Mayo Clin Proc. 2015;90(6):791–800. https://doi.org/10.1016/j.mayocp.2015.03.017 .
doi: 10.1016/j.mayocp.2015.03.017
pubmed: 25957621
Beuers U, Hohenester S, de Buy Wenniger LJ, et al. The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies. Hepatology. 2010;52(4):1489–96. https://doi.org/10.1002/hep.23810 .
doi: 10.1002/hep.23810
pubmed: 20721884
Alvaro D, Mennone A, Boyer JL. Role of kinases and phosphatases in the regulation of fluid secretion and Cl-/HCO3- exchange in cholangiocytes. Am J Physiol. 1997;273(2 Pt 1):G303–13. https://doi.org/10.1152/ajpgi.1997.273.2.G303 .
doi: 10.1152/ajpgi.1997.273.2.G303
pubmed: 9277408
Alvaro D, Alpini G, Jezequel AM, et al. Role and mechanisms of action of acetylcholine in the regulation of rat cholangiocyte secretory functions. J Clin Invest. 1997;100(6):1349–62. https://doi.org/10.1172/JCI119655 .
doi: 10.1172/JCI119655
pubmed: 9294100
pmcid: 508313
Alvaro D, Gigliozzi A, Fraioli F, et al. Hormonal regulation of bicarbonate secretion in the biliary epithelium. Yale J Biol Med. 1997;70(4):417–26.
pubmed: 9626762
pmcid: 2589328
Alvaro D, Gigliozzi A, Marucci L, et al. Corticosteroids modulate the secretory processes of the rat intrahepatic biliary epithelium. Gastroenterology. 2002;122(4):1058–69. https://doi.org/10.1053/gast.2002.32374 .
doi: 10.1053/gast.2002.32374
pubmed: 11910357
Angulo P, Jorgensen RA, Keach JC, et al. Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Hepatology. 2000;31(2):318–23. https://doi.org/10.1002/hep.510310209 .
doi: 10.1002/hep.510310209
pubmed: 10655252
van Hoogstraten HJ, Vleggaar FP, Boland GJ, et al. Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group. Am J Gastroenterol. 2000;95(8): 2015–22. https://doi.org/10.1111/j.1572-0241.2000.02267.x .
Buckley L, Guyatt G, Fink HA, et al. 2017 American College of Rheumatology Guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol. 2017;69(8):1521–37. https://doi.org/10.1002/art.40137 .
doi: 10.1002/art.40137
pubmed: 28585373
Palak J. Trivedi and Gideon M. Hirschfield. Treatment of autoimmune liver disease: current and future therapeutic options. Ther Adv Chronic Dis.. 2013; 4(3): 119–141: https://doi.org/10.1177/2040622313478646 .
Anselmo AC, Mitragotri S. Nanoparticles in the clinic: an update. Bioeng Transl Med. 2019;4(3): e10143. https://doi.org/10.1002/btm2.10143 .
doi: 10.1002/btm2.10143
pubmed: 31572799
pmcid: 6764803
Franze S, Selmin F, Samaritani E, et al. Lyophilization of liposomal formulations: still necessary, still challenging. Pharmaceutics. 2018;10(3). https://doi.org/10.3390/pharmaceutics10030139 .
Sercombe L, Veerati T, Moheimani F, et al. Advances and challenges of liposome assisted drug delivery. Front Pharmacol. 2015;6:286. https://doi.org/10.3389/fphar.2015.00286 .
doi: 10.3389/fphar.2015.00286
pubmed: 26648870
pmcid: 4664963
Sundar S, Kundu J, Kundu SC. Biopolymeric nanoparticles. Sci Technol. Adv Mater. 2010;11(1): 014104. https://doi.org/10.1088/1468-6996/11/1/014104 .
doi: 10.1088/1468-6996/11/1/014104
Liechty WB, Kryscio DR, Slaughter BV, et al. Polymers for drug delivery systems. Annu Rev Chem Biomol Eng. 2010;1:149–73. https://doi.org/10.1146/annurev-chembioeng-073009-100847 .
doi: 10.1146/annurev-chembioeng-073009-100847
pubmed: 22432577
pmcid: 3438887
Jacob J, Haponiuk JT, Thomas S, et al. Biopolymer based nanomaterials in drug delivery systems: a review. Materials Today Chemistry. 2018;9:43–55. https://doi.org/10.1016/j.mtchem.2018.05.002 .
doi: 10.1016/j.mtchem.2018.05.002
Vrignaud S, Benoit JP, Saulnier P. Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles. Biomaterials. 2011;32(33):8593–604. https://doi.org/10.1016/j.biomaterials.2011.07.057 .
doi: 10.1016/j.biomaterials.2011.07.057
pubmed: 21831421
Zoratto N, Montanari E, Viola M, et al. Strategies to load therapeutics into polysaccharide-based nanogels with a focus on microfluidics: a review. Carbohydr Polym. 2021;266: 118119. https://doi.org/10.1016/j.carbpol.2021.118119 .
doi: 10.1016/j.carbpol.2021.118119
pubmed: 34044935
Alhaique F, Casadei MA, Cencetti C, et al. From macro to nano polysaccharide hydrogels: an opportunity for the delivery of drugs. Journal of Drug Delivery Science and Technology. 2016;32:88–99. https://doi.org/10.1016/j.jddst.2015.09.018 .
doi: 10.1016/j.jddst.2015.09.018
Kobayashi T, Chanmee T and Itano N. Hyaluronan: metabolism and function. Biomolecules. 2020;10(11). https://doi.org/10.3390/biom10111525 .
Montanari E, D’Arrigo G, Di Meo C, et al. Chasing bacteria within the cells using levofloxacin-loaded hyaluronic acid nanohydrogels. Eur J Pharm Biopharm. 2014;87(3):518–23. https://doi.org/10.1016/j.ejpb.2014.03.003 .
doi: 10.1016/j.ejpb.2014.03.003
pubmed: 24642185
Montanari E, Di Meo C, Sennato S, et al. Hyaluronan-cholesterol nanohydrogels: characterisation and effectiveness in carrying alginate lyase. N Biotechnol. 2017;37(Pt A):80–9. https://doi.org/10.1016/j.nbt.2016.08.004 .
doi: 10.1016/j.nbt.2016.08.004
pubmed: 27576102
Di Meo C, Montanari E, Manzi L, et al. Highly versatile nanohydrogel platform based on riboflavin-polysaccharide derivatives useful in the development of intrinsically fluorescent and cytocompatible drug carriers. Carbohydr Polym. 2015;115:502–9. https://doi.org/10.1016/j.carbpol.2014.08.107 .
doi: 10.1016/j.carbpol.2014.08.107
pubmed: 25439925
Manzi G, Zoratto N, Matano S, et al. “Click” hyaluronan based nanohydrogels as multifunctionalizable carriers for hydrophobic drugs. Carbohydr Polym. 2017;174:706–15. https://doi.org/10.1016/j.carbpol.2017.07.003 .
doi: 10.1016/j.carbpol.2017.07.003
pubmed: 28821122
Montanari E, Oates A, Di Meo C, et al. Hyaluronan-based nanohydrogels for targeting intracellular S. aureus in human keratinocytes. Adv Healthc Mater. 2018;7(12): e1701483. https://doi.org/10.1002/adhm.201701483 .
D’Arrigo G, Di Meo C, Gaucci E, et al. Self-assembled gellan-based nanohydrogels as a tool for prednisolone delivery. Soft Matter. 2012;8(45):11557. https://doi.org/10.1039/c2sm26178b .
doi: 10.1039/c2sm26178b
D’Arrigo G, Navarro G, Di Meo C, et al. Gellan gum nanohydrogel containing anti-inflammatory and anti-cancer drugs: a multi-drug delivery system for a combination therapy in cancer treatment. Eur J Pharm Biopharm. 2014;87(1):208–16. https://doi.org/10.1016/j.ejpb.2013.11.001 .
doi: 10.1016/j.ejpb.2013.11.001
pubmed: 24215783
Manconi M, Manca ML, Caddeo C, et al. Preparation of gellan-cholesterol nanohydrogels embedding baicalin and evaluation of their wound healing activity. Eur J Pharm Biopharm. 2018;127:244–9. https://doi.org/10.1016/j.ejpb.2018.02.015 .
doi: 10.1016/j.ejpb.2018.02.015
pubmed: 29499300
Fraser JR and Laurent TC. Turnover and metabolism of hyaluronan. Ciba Found Symp. 1989;143(1): 41–53; discussion 53–9, 281–5.
Montanari E, Mancini P, Galli F, et al. Biodistribution and intracellular localization of hyaluronan and its nanogels. A strategy to target intracellular S. aureus in persistent skin infections. J Control Release. 2020;326: 1–12. https://doi.org/10.1016/j.jconrel.2020.06.007 .
Nevi L, Cardinale V, Carpino G, et al. Cryopreservation protocol for human biliary tree stem/progenitors, hepatic and pancreatic precursors. Sci Rep. 2017;7(1):6080. https://doi.org/10.1038/s41598-017-05858-0 .
doi: 10.1038/s41598-017-05858-0
pubmed: 28729654
pmcid: 5519713
Cardinale V, Renzi A, Carpino G, et al. Profiles of cancer stem cell subpopulations in cholangiocarcinomas. Am J Pathol. 2015;185(6):1724–39. https://doi.org/10.1016/j.ajpath.2015.02.010 .
doi: 10.1016/j.ajpath.2015.02.010
pubmed: 25892683
pmcid: 4450332
Cardinale V, Puca R, Carpino G, et al. Adult human biliary tree stem cells differentiate to beta-pancreatic islet cells by treatment with a recombinant human Pdx1 peptide. PLoS ONE. 2015;10(8): e0134677. https://doi.org/10.1371/journal.pone.0134677 .
doi: 10.1371/journal.pone.0134677
pubmed: 26252949
pmcid: 4529196
Carpino G, Nevi L, Overi D, et al. Peribiliary gland niche participates in biliary tree regeneration in mouse and in human primary sclerosing cholangitis. Hepatology. 2020;71(3):972–89. https://doi.org/10.1002/hep.30871 .
doi: 10.1002/hep.30871
pubmed: 31330051
Nevi L, Costantini D, Safarikia S, et al. Cholest-4,6-Dien-3-one promote epithelial-to-mesenchymal transition (EMT) in biliary tree stem/progenitor cell cultures in vitro. Cells. 2019;8(11). https://doi.org/10.3390/cells8111443 .
Nevi L, Carpino G, Costantini D, et al. Hyaluronan coating improves liver engraftment of transplanted human biliary tree stem/progenitor cells. Stem Cell Res Ther. 2017;8(1):68. https://doi.org/10.1186/s13287-017-0492-7 .
doi: 10.1186/s13287-017-0492-7
pubmed: 28320463
pmcid: 5360089
Di Matteo S, Nevi L, Costantini D, et al. The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma. PLoS ONE. 2019;14(1): e0210077. https://doi.org/10.1371/journal.pone.0210077 .
doi: 10.1371/journal.pone.0210077
pubmed: 30677052
pmcid: 6345424
Di Matteo S, Nevi L, Overi D, et al. Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells. Sci Rep. 2021;11(1):2557. https://doi.org/10.1038/s41598-021-81172-0 .
doi: 10.1038/s41598-021-81172-0
pubmed: 33510179
pmcid: 7844056
Pisciotta A, Riccio M, Carnevale G, et al. Human serum promotes osteogenic differentiation of human dental pulp stem cells in vitro and in vivo. PLoS ONE. 2012;7(11): e50542. https://doi.org/10.1371/journal.pone.0050542 .
doi: 10.1371/journal.pone.0050542
pubmed: 23209773
pmcid: 3510089
Nevi L, Di Matteo S, Carpino G, et al. DCLK1, a putative stem cell marker in human cholangiocarcinoma. hepatology. 2021;73(1): 144–159. https://doi.org/10.1002/hep.31571 .
Montanari E, Capece S, Di Meo C, et al. Hyaluronic acid nanohydrogels as a useful tool for BSAO immobilization in the treatment of melanoma cancer cells. Macromol Biosci. 2013;13(9):1185–94. https://doi.org/10.1002/mabi.201300114 .
doi: 10.1002/mabi.201300114
pubmed: 23836462
Montanari E, De Rugeriis MC, Di Meo C, et al. One-step formation and sterilization of gellan and hyaluronan nanohydrogels using autoclave. J Mater Sci Mater Med. 2015;26(1):5362. https://doi.org/10.1007/s10856-014-5362-6 .
doi: 10.1007/s10856-014-5362-6
pubmed: 25578710
Mancinelli R, Franchitto A, Glaser S, et al. Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease. Lab Invest. 2016;96(11):1147–55. https://doi.org/10.1038/labinvest.2016.93 .
doi: 10.1038/labinvest.2016.93
pubmed: 27571215
pmcid: 5480400
Cardinale V, Wang Y, Carpino G, et al. Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets. Hepatology. 2011;54(6):2159–72. https://doi.org/10.1002/hep.24590 .
doi: 10.1002/hep.24590
pubmed: 21809358
Carpino G, Cardinale V, Folseraas T, et al. Neoplastic transformation of the peribiliary stem cell niche in cholangiocarcinoma arisen in primary sclerosing cholangitis. Hepatology. 2019;69(2):622–38. https://doi.org/10.1002/hep.30210 .
doi: 10.1002/hep.30210
pubmed: 30102768
Riehl TE, Alvarado D, Ee X, et al. Hyaluronic acid promotes Lgr5(+) stem cell proliferation and crypt fission through TLR4 and PGE2 transactivation of EGFR. Am J Physiol Gastrointest Liver Physiol. 2020;319(1):G63–73. https://doi.org/10.1152/ajpgi.00242.2019 .
doi: 10.1152/ajpgi.00242.2019
pubmed: 32538139
pmcid: 7468757
Pose E, Sancho-Bru P, Coll M. 3,5-Diethoxycarbonyl-1,4-dihydrocollidine diet: a rodent model in cholestasis research. Methods Mol Biol. 2019;1981:249–57. https://doi.org/10.1007/978-1-4939-9420-5_16 .
doi: 10.1007/978-1-4939-9420-5_16
pubmed: 31016659
Nevi L, Safarikia S, Di Matteo S, et al. Hyaluronan-based grafting strategies for liver stem cell therapy and tracking methods. Stem Cells Int. 2019;2019:3620546. https://doi.org/10.1155/2019/3620546 .
doi: 10.1155/2019/3620546
pubmed: 31354838
pmcid: 6636496
de Santana RB, de Santana CM. Human intrabony defect regeneration with rhFGF-2 and hyaluronic acid - a randomized controlled clinical trial. J Clin Periodontol. 2015;42(7):658–65. https://doi.org/10.1111/jcpe.12406 .
doi: 10.1111/jcpe.12406
pubmed: 25933201
Prestwich GD, Erickson IE, Zarembinski TI, et al. The translational imperative: making cell therapy simple and effective. Acta Biomater. 2012;8(12):4200–7. https://doi.org/10.1016/j.actbio.2012.06.043 .
doi: 10.1016/j.actbio.2012.06.043
pubmed: 22776825
pmcid: 3488131
Turner RA, Wauthier E, Lozoya O, et al. Successful transplantation of human hepatic stem cells with restricted localization to liver using hyaluronan grafts. Hepatology. 2013;57(2):775–84. https://doi.org/10.1002/hep.26065 .
doi: 10.1002/hep.26065
pubmed: 22996260
Gudowska M, Gruszewska E, Panasiuk A, et al. Hyaluronic acid concentration in liver diseases. Clin Exp Med. 2016;16(4):523–8. https://doi.org/10.1007/s10238-015-0388-8 .
doi: 10.1007/s10238-015-0388-8
pubmed: 26354758
Fraser JR, Alcorn D, Laurent TC, et al. Uptake of circulating hyaluronic acid by the rat liver. Cellular localization in situ. Cell Tissue Res. 1985;242(3): 505–10. https://doi.org/10.1007/BF00225415 .
Carpino G, Cardinale V, Renzi A, et al. Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis. J Hepatol. 2015;63(5):1220–8. https://doi.org/10.1016/j.jhep.2015.06.018 .
doi: 10.1016/j.jhep.2015.06.018
pubmed: 26119688
Xue R, Meng Q. The management of glucocorticoid therapy in liver failure. Front Immunol. 2019;10:2490. https://doi.org/10.3389/fimmu.2019.02490 .
doi: 10.3389/fimmu.2019.02490
pubmed: 31749799
pmcid: 6843006
Czaja AJ. Difficult treatment decisions in autoimmune hepatitis. World J Gastroenterol. 2010;16(8):934–47. https://doi.org/10.3748/wjg.v16.i8.934 .
doi: 10.3748/wjg.v16.i8.934
pubmed: 20180231
pmcid: 2828597